fasudil has been researched along with Injuries in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dermal scarring and scar contracture result in restriction of movement." | 1.37 | Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase. ( Bergeron, A; Bond, JE; Kokosis, G; Levinson, H; Ren, L; Selim, MA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bond, JE | 1 |
| Kokosis, G | 1 |
| Ren, L | 1 |
| Selim, MA | 1 |
| Bergeron, A | 1 |
| Levinson, H | 1 |
1 other study available for fasudil and Injuries
| Article | Year |
|---|---|
Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Animals; Biopsy, Needle; Blotting, Western; Ci | 2011 |